SCHEMBL2808367

SCHEMBL2808367

c1ccc(CN2CCc3n[nH]c4nc(N5CCN(Cc6cccnc6)CC5)nc2c34)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 2/20 0.48
CASP5 P51878 2/20 0.48
CASP4 P49662 1/20 0.48
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
GAA P10253 1/20 0.43
DRD2 P14416 2/20 0.42
DRD4 P21917 2/20 0.42
DRD3 P35462 2/20 0.42
MAPK1 P28482 2/20 0.42
TRPA1 O75762 1/20 0.41
CHRNB2 P17787 1/20 0.41
CHRNA4 P43681 1/20 0.41
TRPV6 Q9H1D0 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
OPRL1 P41146 1/20 0.41
MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2810794 0.91 GAA (0.45) CASP1CASP5CASP4KDM4EALDH1A1
SCHEMBL2809641 0.86 ALDH1A1 (0.44) KDM4EALDH1A1GAADRD2DRD4
SCHEMBL2809831 0.86 DRD4 (0.41) CASP1CASP5CASP4KDM4EALDH1A1
SCHEMBL2812360 0.85 DRD4 (0.43) CASP1CASP5KDM4EALDH1A1GAA
SCHEMBL2810576 0.85 ALDH1A1 (0.47) CASP1CASP5KDM4EALDH1A1GAA
SCHEMBL2809499 0.84 HTR6 (0.46) KDM4EALDH1A1GAAHTT
SCHEMBL2809635 0.84 SIGMAR1 (0.50) CASP1CASP5CASP4KDM4EALDH1A1
SCHEMBL2814050 0.84 SIGMAR1 (0.50) CASP1CASP5CASP4KDM4EALDH1A1
SCHEMBL2812018 0.84 CASP1 (0.43) CASP1CASP5CASP4TDP1GAA
SCHEMBL2812038 0.84 BRS3 (0.44) CASP1CASP5GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 CASP1 1745/4885CASP5 574/4885CASP4 1595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.